RTTNews | Sep 7, 2021 08:18AM EDT

08:18 Tuesday, September 7, 2021 (RTTNews) - Global Blood Therapeutics: FDA Accepts Priority Review SNDA For Oxbryta For Sickle Cell Disease In Children Ages 4-11

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved